IBDEI04R ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1799,2)
 ;;=^269771
 ;;^UTILITY(U,$J,358.3,1800,0)
 ;;=I72.2^^11^156^7
 ;;^UTILITY(U,$J,358.3,1800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1800,1,3,0)
 ;;=3^Aneurysm of Renal Artery
 ;;^UTILITY(U,$J,358.3,1800,1,4,0)
 ;;=4^I72.2
 ;;^UTILITY(U,$J,358.3,1800,2)
 ;;=^269773
 ;;^UTILITY(U,$J,358.3,1801,0)
 ;;=I72.3^^11^156^5
 ;;^UTILITY(U,$J,358.3,1801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1801,1,3,0)
 ;;=3^Aneurysm of Iliac Artery
 ;;^UTILITY(U,$J,358.3,1801,1,4,0)
 ;;=4^I72.3
 ;;^UTILITY(U,$J,358.3,1801,2)
 ;;=^269775
 ;;^UTILITY(U,$J,358.3,1802,0)
 ;;=I72.4^^11^156^6
 ;;^UTILITY(U,$J,358.3,1802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1802,1,3,0)
 ;;=3^Aneurysm of Lower Extremity Artery
 ;;^UTILITY(U,$J,358.3,1802,1,4,0)
 ;;=4^I72.4
 ;;^UTILITY(U,$J,358.3,1802,2)
 ;;=^269777
 ;;^UTILITY(U,$J,358.3,1803,0)
 ;;=I72.0^^11^156^4
 ;;^UTILITY(U,$J,358.3,1803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1803,1,3,0)
 ;;=3^Aneurysm of Carotid Artery
 ;;^UTILITY(U,$J,358.3,1803,1,4,0)
 ;;=4^I72.0
 ;;^UTILITY(U,$J,358.3,1803,2)
 ;;=^5007793
 ;;^UTILITY(U,$J,358.3,1804,0)
 ;;=I72.8^^11^156^3
 ;;^UTILITY(U,$J,358.3,1804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1804,1,3,0)
 ;;=3^Aneurysm of Arteries NEC
 ;;^UTILITY(U,$J,358.3,1804,1,4,0)
 ;;=4^I72.8
 ;;^UTILITY(U,$J,358.3,1804,2)
 ;;=^5007794
 ;;^UTILITY(U,$J,358.3,1805,0)
 ;;=I73.00^^11^156^84
 ;;^UTILITY(U,$J,358.3,1805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1805,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,1805,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,1805,2)
 ;;=^5007796
 ;;^UTILITY(U,$J,358.3,1806,0)
 ;;=I73.1^^11^156^91
 ;;^UTILITY(U,$J,358.3,1806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1806,1,3,0)
 ;;=3^Thromboangiitis Obliterans
 ;;^UTILITY(U,$J,358.3,1806,1,4,0)
 ;;=4^I73.1
 ;;^UTILITY(U,$J,358.3,1806,2)
 ;;=^5007798
 ;;^UTILITY(U,$J,358.3,1807,0)
 ;;=I73.9^^11^156^83
 ;;^UTILITY(U,$J,358.3,1807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1807,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,1807,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,1807,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,1808,0)
 ;;=I74.01^^11^156^85
 ;;^UTILITY(U,$J,358.3,1808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1808,1,3,0)
 ;;=3^Saddle Embolus of Abdominal Aorta
 ;;^UTILITY(U,$J,358.3,1808,1,4,0)
 ;;=4^I74.01
 ;;^UTILITY(U,$J,358.3,1808,2)
 ;;=^340522
 ;;^UTILITY(U,$J,358.3,1809,0)
 ;;=I74.09^^11^156^10
 ;;^UTILITY(U,$J,358.3,1809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1809,1,3,0)
 ;;=3^Arterial Embolism/Thrombosis of Abdominal Aorta NEC
 ;;^UTILITY(U,$J,358.3,1809,1,4,0)
 ;;=4^I74.09
 ;;^UTILITY(U,$J,358.3,1809,2)
 ;;=^340523
 ;;^UTILITY(U,$J,358.3,1810,0)
 ;;=I74.11^^11^156^70
 ;;^UTILITY(U,$J,358.3,1810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1810,1,3,0)
 ;;=3^Embolism/Thrombosis of Thoracic Aorta
 ;;^UTILITY(U,$J,358.3,1810,1,4,0)
 ;;=4^I74.11
 ;;^UTILITY(U,$J,358.3,1810,2)
 ;;=^269787
 ;;^UTILITY(U,$J,358.3,1811,0)
 ;;=I74.2^^11^156^73
 ;;^UTILITY(U,$J,358.3,1811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1811,1,3,0)
 ;;=3^Embolism/Thrombosis of Upper Extremity Arteries
 ;;^UTILITY(U,$J,358.3,1811,1,4,0)
 ;;=4^I74.2
 ;;^UTILITY(U,$J,358.3,1811,2)
 ;;=^5007801
 ;;^UTILITY(U,$J,358.3,1812,0)
 ;;=I74.3^^11^156^68
 ;;^UTILITY(U,$J,358.3,1812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1812,1,3,0)
 ;;=3^Embolism/Thrombosis of Lower Extremity Arteries
 ;;^UTILITY(U,$J,358.3,1812,1,4,0)
 ;;=4^I74.3
 ;;^UTILITY(U,$J,358.3,1812,2)
 ;;=^5007802
 ;;^UTILITY(U,$J,358.3,1813,0)
 ;;=I74.5^^11^156^67
